Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Reports Record-Level Life Science/Chem Revenues for Q4

NEW YORK, Nov. 18 (GenomeWeb News) - Agilent Technologies yesterday posted an eight percent year-over-year increase in revenues for its Life Science and Chemical Analysis business unit for its fourth fiscal quarter ended Oct. 31, 2003.

The Life Science and Chemical Analysis segment, which includes capillary electrophoresis, GC and GC/MS, LC and LC/MS, informatics, microarrays, lab-on-a-chip, and other products and services, brought in $331 million during the quarter, compared to $298 million in the year-ago period. The segment accounted for 19 percent of the company's total quarterly revenues of $1.68 billion, which includes revenues from its Test and Measurement, Semiconductor Products, and Automated Test business units. 

Aglient said revenues for the Life Science and Chemical Analysis segment were at record levels for the quarter. The segment posted an operating profit of $53 million for the quarter, up from $43 million in the year-ago period.

Agilent spent $221 million in R&D across all four of its business units for the fourth quarter, down from $322 million in the year-ago period.

The company reported overall net income of $13 million for the quarter, compared to a loss of $236 million for the same period last year.  

Agilent ended the quarter with around $1.6 billion in cash and equivalents.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.